Search

everythinglearnresearchcommunity

for

Search:↓

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Finasteride can cause enlarged breasts.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.

Topical finasteride can cause breast enlargement and tenderness in men.